SCHEMBL6565776

SCHEMBL6565776

CCOC(=O)CSc1nc(Cl)cc(-c2ccccc2)n1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.70
ALDH1A1 P00352 3/20 0.70
MAPK1 P28482 2/20 0.70
POLB P06746 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MAPT P10636 3/20 0.55
ABCB1 P08183 1/20 0.54
RXFP1 Q9HBX9 3/20 0.52
ALOX5 P09917 2/20 0.52
APEX1 P27695 1/20 0.51
PRNP P04156 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PTGS2 P35354 1/20 0.50
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11848556 0.86 L3MBTL1 (0.71) L3MBTL1ALDH1A1MAPK1POLBSMN1; SMN2
SCHEMBL6827151 0.84 KDM4E (0.58) L3MBTL1ALDH1A1MAPK1MAPTABCB1
SCHEMBL6565546 0.81 ALOX5 (0.68) L3MBTL1ALDH1A1MAPK1SMN1; SMN2MAPT
SCHEMBL6565628 0.80 PPARA (0.72) L3MBTL1ALDH1A1MAPK1SMN1; SMN2MAPT
SCHEMBL13469926 0.79 L3MBTL1 (0.61) L3MBTL1ALDH1A1MAPK1POLBSMN1; SMN2
SCHEMBL3451654 0.79 KDM4E (0.57) L3MBTL1ALDH1A1MAPK1SMN1; SMN2MAPT
SCHEMBL23269354 0.78 KDM4E (0.69) L3MBTL1ALDH1A1MAPK1POLBMAPT
SCHEMBL6562061 0.78 L3MBTL1 (0.61) L3MBTL1ALDH1A1SMN1; SMN2MAPTABCB1
SCHEMBL3451673 0.77 ALDH1A1 (0.54) L3MBTL1ALDH1A1MAPK1POLBSMN1; SMN2
SCHEMBL3450613 0.76 KDM4E (0.50) L3MBTL1ALDH1A1MAPK1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820654-B2 Pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-26 US disclosed
US-7820654-B2 Pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-26 US disclosed
EP-1399426-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING BETA-AMYLOID PRODUCTION Active Pass Pharmaceuticals, Inc. (CA) 2004-03-24 EP disclosed
US-20030191144-A1 Compounds, compositions and methods for modulating beta-amyloid production ACTIVE PASS PHARMACEUTICALS, INC. (CA) 2003-10-09 US disclosed
US-20030125338-A1 Compounds, compositions and methods for modulating beta-amyloid production ACTIVE PASS PHARMACEUTICALS, INC. (CA) 2003-07-03 US disclosed
WO-2002100836-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING BETA-AMYLOID PRODUCTION ACTIVE PASS PHARMACEUTICALS, INC. (CA) 2002-12-19 WO disclosed
US-3940394-A ANTILIPEMIC SANTILLI ARTHUR A 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125338-A1 Compounds, compositions and methods for modulating beta-amyloid production APP, PPARA, PPARG L3MBTL1 4771/4885ALDH1A1 1910/4885MAPK1 2773/4885
US-20030191144-A1 Compounds, compositions and methods for modulating beta-amyloid production APP, PPARA, PPARG L3MBTL1 4771/4885ALDH1A1 1910/4885MAPK1 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.